We named our company Espero because it means hope. And that’s what we seek to provide everyone who takes our innovative cardiovascular medicines. Hope for improved health and hope for a better tomorrow.
Espero BioPharma is a pharmaceutical company focused on the development of drugs for unmet needs in thrombosis and cardiac rhythm control. The Company is developing tecarfarin for patients requiring chronic anticoagulation and an anti-arrhythmic drug (AAD) program to treat atrial fibrillation (AFib). Tecarfarin and our AAD compounds were designed so that metabolic clearance is not hindered by the body, creating the potential for increased efficacy with a superior safety profile.